152 related articles for article (PubMed ID: 37709306)
1. Protocol for the ASTRO study (SSOP-01): a multicentre prospective cohort study investigating adverse events based on electronic patient-reported outcomes in patients with breast cancer after adjuvant chemotherapy.
Kuniyoshi O; Sano M; Nakano Y; Kawaguchi T; Hatakeyama T; Tsuchiya Y; Inada Y; Harada T; Kurosaki M; Mashiko T; Miyaji T; Yamaguchi T
BMJ Open; 2023 Sep; 13(9):e071500. PubMed ID: 37709306
[TBL] [Abstract][Full Text] [Related]
2. Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study.
Hirata T; Kawaguchi T; Azuma K; Torii A; Usui H; Kim S; Hayama T; Hirate D; Kawahara Y; Kumihashi Y; Chisaka T; Wako T; Yoshimura A; Miyaji T; Yamaguchi T
BMJ Open; 2023 Nov; 13(11):e073724. PubMed ID: 37993166
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal study of symptom burden in outpatients with advanced cancers based on electronic Patient-Reported Outcome (ePRO) platform: a single institution, prospective study protocol.
Tang L; Pang Y; He Y; Shi Q; Han X; Li Z; Zhou C; Zhou Y; He S; Wang Y; Zhang Y; Song L; Wang B; Li X
BMJ Open; 2020 Nov; 10(11):e038223. PubMed ID: 33444183
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Improving prediction of response to neoadjuvant treatment in patients with breast cancer by combining liquid biopsies with multiparametric MRI: protocol of the LIMA study - a multicentre prospective observational cohort study.
Janssen LM; Suelmann BBM; Elias SG; Janse MHA; van Diest PJ; van der Wall E; Gilhuijs KGA
BMJ Open; 2022 Sep; 12(9):e061334. PubMed ID: 36127090
[TBL] [Abstract][Full Text] [Related]
6. Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.
Tan AR; Im SA; Mattar A; Colomer R; Stroyakovskii D; Nowecki Z; De Laurentiis M; Pierga JY; Jung KH; Schem C; Hogea A; Badovinac Crnjevic T; Heeson S; Shivhare M; Kirschbrown WP; Restuccia E; Jackisch C;
Lancet Oncol; 2021 Jan; 22(1):85-97. PubMed ID: 33357420
[TBL] [Abstract][Full Text] [Related]
7. Multicentre, randomised, double-blind, placebo-controlled phase II study of prophylactic olanzapine for patients with metastatic breast cancer receiving T-DXd treatment: protocol for the ERICA study (WJOG14320B).
Sakai H; Tsurutani J; Ozaki Y; Ishiguro H; Nozawa K; Watanabe K; Maeda S; Yokoe T; Imamura CK; Matsumoto K; Iwasa T; Chiba Y; Takiguchi D; Takano T
BMJ Open; 2023 Apr; 13(4):e070304. PubMed ID: 37012013
[TBL] [Abstract][Full Text] [Related]
8. Chinese multicentre prospective registry of breast cancer patient-reported outcome-reconstruction and oncoplastic cohort (PRO-ROC): a study protocol.
Li L; Yang B; Li H; Yin J; Jin F; Han S; Liao N; Shi J; Ling R; Li Z; Ouyang L; Wang X; Fu P; Ouyang Z; Ma B; Wu X; Wang H; Liu J; Shao Z; Wu J
BMJ Open; 2019 Dec; 9(12):e032945. PubMed ID: 31843846
[TBL] [Abstract][Full Text] [Related]
9. Body composition and chemotherapy toxicity in women with early breast cancer (CANDO-3): protocol for an observational cohort study.
Durkin K; Heetun A; Ewings S; Munday R; Wootton SA; Turner L; Copson ER; ; Cutress RI
BMJ Open; 2022 Feb; 12(2):e054412. PubMed ID: 35193913
[TBL] [Abstract][Full Text] [Related]
10. Protocol for a multicentre, prospective, cohort study to investigate patient satisfaction and quality of life after immediate breast reconstruction in Japan: the SAQLA study.
Saiga M; Hosoya Y; Utsunomiya H; Kuramoto Y; Watanabe S; Tomita K; Aihara Y; Muto M; Hikosaka M; Kawaguchi T; Miyaji T; Yamaguchi T; Zenda S; Goto A; Sakuraba M; Kusano T; Miyabe K; Kuroki T; Yano T; Taminato M; Sekido M; Tsunoda Y; Satake T; Doihara H; Kimata Y
BMJ Open; 2021 Feb; 11(2):e042099. PubMed ID: 33589456
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy in early breast cancer.
Ejlertsen B
Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
[TBL] [Abstract][Full Text] [Related]
12. The iBRA-2 (immediate breast reconstruction and adjuvant therapy audit) study: protocol for a prospective national multicentre cohort study to evaluate the impact of immediate breast reconstruction on the delivery of adjuvant therapy.
Dave R; O'Connell R; Rattay T; Tolkien Z; Barnes N; Skillman J; Williamson P; Conroy E; Gardiner M; Harnett A; O'Brien C; Blazeby J; Potter S; Holcombe C;
BMJ Open; 2016 Oct; 6(10):e012678. PubMed ID: 27855106
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol.
Krzyzanowska MK; Julian JA; Powis M; Howell D; Earle CC; Enright KA; Mittmann N; Trudeau ME; Grunfeld E
BMC Cancer; 2019 Sep; 19(1):884. PubMed ID: 31488084
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of oral administration of cystine and theanine in patients with colorectal cancer undergoing capecitabine-based adjuvant chemotherapy after surgery: study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled, phase II trial.
Hamaguchi R; Tsuchiya T; Miyata G; Sato T; Takahashi K; Ariyoshi K; Oyamada S; Iwase S
BMJ Open; 2018 Jul; 8(7):e021442. PubMed ID: 30030317
[TBL] [Abstract][Full Text] [Related]
15. Developing and validating utility parameters to establish patient-reported outcome-based perioperative symptom management in patients undergoing prostatectomy: a multicentre, prospective, observational cohort study protocol.
Li J; Chen T; Gao J; Peng F; Gu T; Jin B
BMJ Open; 2023 Aug; 13(8):e074763. PubMed ID: 37553190
[TBL] [Abstract][Full Text] [Related]
16. CapeOX perioperative chemotherapy versus postoperative chemotherapy for locally advanced resectable colon cancer: protocol for a two-period randomised controlled phase III trial.
Liu F; Tong T; Huang D; Yuan W; Li D; Lin J; Cai S; Xu Y; Chen W; Sun Y; Zhuang J
BMJ Open; 2019 Jan; 9(1):e017637. PubMed ID: 30700474
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial.
von Minckwitz G; Colleoni M; Kolberg HC; Morales S; Santi P; Tomasevic Z; Zhang N; Hanes V
Lancet Oncol; 2018 Jul; 19(7):987-998. PubMed ID: 29880292
[TBL] [Abstract][Full Text] [Related]
19. Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer.
Montemurro F; Mittica G; Cagnazzo C; Longo V; Berchialla P; Solinas G; Culotta P; Martinello R; Foresto M; Gallizioli S; Calori A; Grasso B; Volpone C; Bertola G; Parola G; Tealdi G; Giuliano PL; Aglietta M; Ballari AM
JAMA Oncol; 2016 Apr; 2(4):445-52. PubMed ID: 26720497
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of psychological distress and associated factors among patients undergoing comprehensive genomic profiling testing: protocol for a multicentre, prospective, observational study.
Matsuoka A; Fujimori M; Koyama T; Sato A; Mori K; Hirata M; Tanabe N; Nakachi K; Kato S; Okamoto H; Ogawa K; Komatsu H; Iwasaku M; Miyaji T; Uchitomi Y
BMJ Open; 2023 Nov; 13(11):e072472. PubMed ID: 37996226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
